Primary carnitine deficiency: diagnosis after heart transplantation : better late than never!

Primary carnitine deficiency due to mutations in the SLC22A5 gene is a rare but well-treatable metabolic disorder that puts patients at risk for metabolic decompensations, skeletal and cardiac myopathy and sudden cardiac death.

Saved in:
Bibliographic Details
Main Authors: Grünert, Sarah (Author) , Tucci, Sara (Author) , Schumann, Anke (Author) , Schwendt, Meike (Author) , Gramer, Gwendolyn (Author) , Hoffmann, Georg F. (Author) , Erbel, Michelle (Author) , Stiller, Brigitte (Author) , Spiekerkötter, Ute (Author)
Format: Article (Journal)
Language:English
Published: 10 April 2020
In: Orphanet journal of rare diseases
Year: 2020, Volume: 15, Pages: 1-6
ISSN:1750-1172
DOI:10.1186/s13023-020-01371-2
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13023-020-01371-2
Get full text
Author Notes:Sarah C. Grünert, Sara Tucci, Anke Schumann, Meike Schwendt, Gwendolyn Gramer, Georg F. Hoffmann, Michelle Erbel, Brigitte Stiller and Ute Spiekerkoetter
Description
Summary:Primary carnitine deficiency due to mutations in the SLC22A5 gene is a rare but well-treatable metabolic disorder that puts patients at risk for metabolic decompensations, skeletal and cardiac myopathy and sudden cardiac death.
Item Description:Gesehen am 12.05.2020
Physical Description:Online Resource
ISSN:1750-1172
DOI:10.1186/s13023-020-01371-2